至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The potential mechanisms and material basis of Fuzheng Jiedu decoction broad-spectrum inhibiting coronaviruses

VIROLOGICA SINICA. 2013-01; 
Ke Liu; Bixia Hong; Shi-Ting He; Siying Du; Jiayi Ke; Lili Tian; Tao Tao; Yihan Zhang; Kelin Li; Han Chang; Mengzhe Li; Xiaoping An; Lihua Song; Zhongde Zhang; Liang Liu; Hudan Pan; Huahao Fan; Yigang Tong
Products/Services Used Details Operation
Protein and Antibody Reagents on 10% SDS-PAGE gel and then transferred to a PVDF (polyvinylidene fluoride) membrane. Anti-SARS-CoV-2 nucleocapsid protein antibody (Cat. No. Z03488; Genscript, China) and anti-GAPDH antibody (Cat. No. 60004 1 1-IG; Proteintech, China) were used, diluted at 1:3000 and 1:10,000, respectively. HRP-conjugated Affinipure Get A Quote

摘要

Traditional Chinese medicine has unique advantages in preventing and treating COVID-19, and Fuzheng Jiedu decoction (FZJDD) was reported to be effective against COVID-19 in clinical trials. To investigate the potential mechanisms and material basis of FZJDD against SARS-CoV-2, we performed SARS-CoV-2 target protein inhibition analyses and a metabolite full spectrum analysis of FZJDD. Interestingly, FZJDD was found to block the binding of SARS-CoV-2 Spike protein with the receptor ACE2 and inhibit the activity of SARS-CoV-2 3CLpro. Moreover, FZJDD can regulate the TNF and the MAPK signaling pathway to inhibit the inflammatory response and alleviate the cytokine storm . A total of 298 compounds were identified in... More

关键词

Fuzheng jiedu decoction, SARS-CoV-2, Broad-spectrum anti-coronavirus, Traditional Chinese medicine, Caffeic acid, Octyl gallate